Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Stanford research sheds light on key trigger of embryonic stem cell differentiation

Stanford research sheds light on key trigger of embryonic stem cell differentiation

November 06, 2008

STANFORD, Calif. - Clusters of mouse embryonic stem cells called embryoid bodies more closely approximate true embryos in organization and structure than previously thought, according to researchers at the Stanford University School of Medicine. Harnessing the signals that influence the cells' fate may help researchers more accurately direct the differentiation of embryonic stem cells for use in therapy.

The researchers found that embryoid bodies have hallmarks of gastrulation - a remarkable developmental step that launches a hollow ball of cells toward becoming an organism with three distinct types of precursor cells. The scientists showed that this process is initiated by a single signaling pathway in embryoid bodies and in real embryos. Enhancing or blocking this signal affects what the cells become, the scientists found.




"A lot of embryonic stem cell research is aimed at devising ways to help the cells differentiate along a particular path," said Roeland Nusse, PhD, professor of developmental biology. "But it's very difficult to know how to do this. We're learning that they do more things in culture than we previously thought; at the same time, we're developing more tools to control what they become."

Nusse is the senior author of the research, which will be published in the Nov. 6 issue of the journal Cell Stem Cell. He is also a Howard Hughes Medical Institute investigator and a member of Stanford's Cancer Center. The study was funded in part by a grant from the California Institute of Regenerative Medicine intended to clarify the role of a common group of cell signaling molecules called the Wnt family in the differentiation of embryonic stem cells.

Nusse and the first authors of the paper, postdoctoral scholar Derk ten Berge, PhD, and undergraduate student Wouter Koole, used easily tracked reporter genes that are expressed only when cells are responding to Wnt signals to figure out when and where Wnt is active in mouse embryos and embryoid bodies. Embryoid bodies are clumps of embryonic stem cells that can to begin to differentiate into different tissues but they are not true embryos.

Using this system, the researchers learned that Wnt-responsive cells first appear in 6.5-day-old embryos in an area called the primitive streak that forms on what will become the posterior side of the embryo. It is the first step toward gastrulation, in which an outer layer of cells dimples inward at what will be either the mouth or anus to form the three distinct precursor cell types shared by most animals: the ectoderm, or outer layer, which forms neurons, skin cells and pigment; the endoderm, or inner layer, which forms many of the organs; and mesoderm, or middle layer, which forms muscle and red blood cells.

More importantly, Nusse and his colleagues determined that Wnt-responsive cells in the embryoid bodies also spontaneously form a primitive streak, though they never truly gastrulate. Supplementing the naturally occurring Wnt signal with "extra" Wnt protein accelerated the formation of the primitive streak, and adding proteins that blocked Wnt activity inhibited it.

"We knew that embryoid bodies did exhibit some self-organization," said Nusse. "They form a hollow cavity with inner and outer cell layers. But the primitive streak is the first indication we have that they can develop the kind of asymmetry that is seen in embryos."

Furthermore, the extra Wnt caused the Wnt-responsive cells to differentiate primarily into mesendodermal precursors (which can become either mesoderm or endoderm and is associated with the posterior of the embryo) and inhibited the formation of neurectoderm (ectoderm destined to become cells of the nervous system that are mostly associated with the embryo's anterior). Blocking Wnt activity tipped the balance in the other direction, causing the cells to shun mesendoderm and become mainly neurectoderm.

The first step to controlling cell fate is to understand which protein in the normal cocktail of growth factors used to maintain the embryoid bodies is responsible for triggering the cells' Wnt-responsive pathways. The researchers identified one specific factor, called bmp, that gets the ball rolling. Inhibiting this factor stops the spontaneous formation of the primitive streak in the embryoid bodies and gives the researcher more precise control over the cells' differentiation.

"Differentiation is a step-wise process," said Nusse. "To get to a particular endpoint, you need to know all the steps along the way. Our research indicates that embryoid bodies are a better-than-expected model of what happens in the embryo, and suggests how we may be able to manipulate those steps to our advantage to get pure populations of certain types of cells for research or therapy."

Stanford University Medical Center



Related Embryonic Stem Cells Current Events and Embryonic Stem Cells News Articles Embryonic Stem Cells Current Events and Embryonic Stem Cells News RSS Embryonic Stem Cells Current Events and Embryonic Stem Cells News RSS
New research shows versatility of amniotic fluid stem cells
For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought.

First reconstitution of an epidermis from human embryonic stem cells
Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM* Institute (I-STEM/ Inserm UEVE U861/AFM), published in the Lancet on 21 November 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells.

UCI embryonic stem cell therapy restores walking ability in rats with neck injuries
The first human embryonic stem cell treatment approved by the FDA for human testing has been shown to restore limb function in rats with neck spinal cord injuries - a finding that could expand the clinical trial to include people with cervical damage.

Of mice and men: Stem cells and ethical uncertainties
The recent creation of live mice from induced pluripotent stem cells (iPSCs) not only represents a remarkable scientific achievement, but also raises important issues, according to bioethicists at The Johns Hopkins University's Berman Institute of Bioethics.

NIH-funded researchers transform embryonic stem cells into human germ cells
Researchers funded in part by the National Institutes of Health have discovered how to transform human embryonic stem cells into germ cells, the embryonic cells that ultimately give rise to sperm and eggs.

Placental precursor stem cells require testosterone-free environment to survive
Trophoblast stem cells (TSCs), cells found in the layer of peripheral embryonic stem cells from which the placenta is formed, are thought to exhibit "immune privilege" that aids cell survivability and is potentially beneficial for cell and gene therapies.

Endocrine Society calls for expanded scope and funding for stem cell research
Stem cell research holds great promise for the treatment of millions of Americans with debilitating and possibly fatal diseases.

Small mechanical forces have big impact on embryonic stem cells
Applying a small mechanical force to embryonic stem cells could be a new way of coaxing them into a specific direction of differentiation, researchers at the University of Illinois report. Applications for force-directed cell differentiation include therapeutic cloning and regenerative medicine.

Fate Therapeutics announces creation of small molecule platform for commercial-scale reprogramming
Fate Therapeutics, Inc. announced today the generation of human induced-pluripotent stem cells (iPSCs) using a combination of small molecules that significantly improves the speed and efficiency of reprogramming.

A major step in making better stem cells from adult tissue
October 15, 2009 A team led by scientists from The Scripps Research Institute has developed a method that dramatically improves the efficiency of creating stem cells from human adult tissue, without the use of embryonic cells.
More Embryonic Stem Cells Current Events and Embryonic Stem Cells News Articles
Embryonic Stem Cells: A Practical Approach (The Practical Approach Series)

Embryonic Stem Cells: A Practical Approach (The Practical Approach Series)
by Elena Notarianni (Editor), Martin J. Evans (Editor)

The groundbreaking isolation of embryonic stem cells (or 'ES cells') of the mouse in the early 1980s triggered a sustained expansion of global research into their exploitation. This led to the routine genetic engineering of the mouse and revolutionised our understanding of biological processes in the context of the whole animal. ES cell biology remains a crucial and growing area of research with far-reaching implications for developmental and comparative biology as well as for human health.
This book serves as a primer to ES cells, their derivation and experimental manipulation. It contains a broad compendium of methods of direct relevance to both graduate students and specialist researchers. An introductory chapter by the principle originator of ES cell research outlines the...

Lines That Divide: The Great Stem Cell Debate

Lines That Divide: The Great Stem Cell Debate
Directed By: Brian Godawa
Also With: Jack Hafer (Producer), Jennifer Lahl (Producer)

With the Obama administration recently announcing its policy change on the issue of stem cell research and regenerative medicine, the questions surrounding this issue are increasingly more complex. This is why Lines That Divide: The Great Stem Cell Debate, a feature length documentary on stem cell research was made. Is stem cell research a potential miracle cure for diseases or a form of biological colonialism? The debate still rages over this controversial science. Supporters argue that it is our moral duty to pursue scientific progress that provides healing hope for humanity. Detractors argue that the ends don't justify the means in harvesting some human life to save others places our nations heart and soul on the same path as Germany in the late 1930's. This documentary seeks to...

The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy (Basic Bioethics)

The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy (Basic Bioethics)
by Suzanne Holland (Editor), Karen Lebacqz (Editor), Laurie Zoloth (Editor)

Human embryonic stem cells can divide indefinitely and have the potential to develop into many types of tissue. Research on these cells is essential to one of the most intriguing medical frontiers, regenerative medicine. It also raises a host of difficult ethical issues and has sparked great public interest and controversy. This book offers a foundation for thinking about the many issues involved in human embryonic stem cell research. It considers questions about the nature of human life, the limits of intervention into human cells and tissues, and the meaning of our corporeal existence. The fact that stem cells may be derived from living embryos that are destroyed in the process or from aborted fetuses ties the discussion of stem cell research to the ongoing debates on abortion. In...

Human Embryonic Stem Cells: An Introduction to the Science and Therapeutic Potential

Human Embryonic Stem Cells: An Introduction to the Science and Therapeutic Potential
by Ann A. Kiessling (Author), Scott. C. Anderson (Author)

The social debate and resulting moratorium by the Bush Administration against federal funding for research involving the creation of human embryos for stem cell therapy prompted the writing of this text. The emerging field of human embryonic stem cell biomedicine crosses many disciplinary boundaries - cell biology, reproductive biology, embryology, molecular biology, endocrinology, immunology, fetal medicine, transplantation medicine and surgery. This single reference provides basic information from these multiple disciplines as it pertains to the science of stem cells.

Charlie Rose with Gerald Fischbach, Silviu Itescu, Bill Futrell, Arlen Specter & Sam Brownback; Christopher Reeve (May 4, 2001)

Charlie Rose with Gerald Fischbach, Silviu Itescu, Bill Futrell, Arlen Specter & Sam Brownback; Christopher Reeve (May 4, 2001)

A panel on stem cell research featuring Dr. Gerald Fischbach, Dean of the Columbia Medical School, Dr. Silviu Itescu, Director of Transplantation Immunology at Columbia, Dr. Bill Futrell, President-Elect of the American Association of Plastic Surgeons, Pennsylvania Senator Arlen Specter and Kansas Senator Sam Brownback. They share their thoughts on the medical benefits that the use of stem cells will lead to and the ethical questions that are implicit in this medical procedure. Then, Christopher Reeve is on to give his opinion on the topic and encourages pushing ahead with research.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

Human Embryonic Stem Cells: The Practical Handbook

Human Embryonic Stem Cells: The Practical Handbook
by Stephen Sullivan (Editor), Chad A Cowan (Editor), Kevin Eggan (Editor)

With this valuable practical guide, three members of the Harvard Stem Cell Institute have compiled and edited the definite handbook for the exciting new field of human embryonic stem cell research. The editors have gathered protocols from scientists with extensive reputation and expertise, describing and comparing currently used techniques for the culture of human stem cells and discussing the strengths and weaknesses of the different approaches.

Human Embryonic Stem Cells: The Practical Handbook contains the first centralised collection of methods used in human embryonic stem cell biology. The book covers the derivation of human stem cell lines, the obtaining of cells from human stem cell banks, the culturing and characterisation of the cells, and the differentiation of the...

Charlie Rose (August 9, 2001)

Charlie Rose (August 9, 2001)

In this rebroadcast of an hour that originally aired on May 4, 2001, a panel discusses their reactions to President Bush's announcement to allow limited federal funding for embryonic stem cell research. They are: Bill Kristol, Editor of The Weekly Standard Magazine, Senator Sam Brownback, Dr. Gerald Fischbach, Dean of the School of Medicine at Columbia University, Sharon Begley, senior editor at Newsweek Magazine, and Eric Pooley, an editor at Time Magazine.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

Human Embryonic Stem Cell Protocols (Methods in Molecular Biology)

Human Embryonic Stem Cell Protocols (Methods in Molecular Biology)
by Kursad Turksen (Editor)

Despite political and ethical controversies surrounding the study of human embryonic stem (hES) cells, new freedoms in regard to using them for research has allowed interest to remain high in understanding the regulatory mechanisms of stem cell self-renewal, their differentiation along various lineages, and their potential use in regenerative medicine. In Human Embryonic Stem Cell Protocols, Second Edition, internationally respected researchers expand upon the popular first edition and describe in detail their most useful techniques for the molecular and cellular manipulation of these intriguing cells. This diverse collection of readily reproducible methods has been optimized for the derivation, characterization, and differentiation of hES cells, with special attention given to...

Should the Government Fund Embryonic Stem Cell Research? (At Issue Series)

Should the Government Fund Embryonic Stem Cell Research? (At Issue Series)
by Amy Francis (Editor)



ABC News Nightline Henry's Story

ABC News Nightline Henry's Story

For every medical breakthrough, there are many more patients who undergo experimental treatment only to see it fail. But even though the treatment fails, the patient still plays an important role, and offers a generous gift to our overall understanding of science. Laurie Strongin and Allen Goldberg did not seek the role they played in medical research. They found themselves there unexpectedly in 1995 when their first born, Henry, was diagnosed with a rare and deadly disease called Fanconi Anemia. Immediately, they were thrust onto the frontlines of medical research. Before Henry was a toddler they found themselves in the middle of a debate that would soon grip the nation over embryonic tissue research. But for Laurie and Allen there was never a debate. Doctors told them that the best...

© 2009 BrightSurf.com